Antidepressant Trials Exclude Vast Majority of Depressed Patients

More than 80% of depressed patients would be deemed ineligible for clinical trials of antidepressant drugs due to strict exclusion criteria.

A provocative new study suggests that more than 80% of people with depression in the general population aren’t eligible for clinical trials of antidepressant drugs.

Researchers comment that at least five patients would need to be screened to enroll just one patient meeting the typical inclusion and exclusion criteria for antidepressant registration trials (ARTs).

Drs. Sheldon Preskorn and Matthew Macaluso of University of Kansas School of Medicine-Wichita and Dr. Madhukar Trivedi of Southwestern Medical School in Dallas led the study.

The investigation illuminates some major differences between patients with depression seen in everyday clinical practice and those enrolled in ARTs. This awareness is meaningful as ARTs commonly lead to FDA drug approval for depression medications.

READ FULL ARTICLE Curated publisher From Psych Central